Moleculin Biotech Inc (NASDAQ:MBRX)

Delayed Data
As of 3:59pm ET
 +0.07 / +1.81%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Moleculin Biotech Inc have a median target of 18.00, with a high estimate of 29.00 and a low estimate of 14.00. The median estimate represents a +358.02% increase from the last price of 3.93.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Moleculin Biotech Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.67%
Growthannually 54.54%


Growthquarterly 10.00%
Growthannually --
Key to the earnings and sales forecast charts.